Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 5, 2006, Pages

  Chattopadhyay, Naibedya ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cytokine; G protein coupled receptor; Metastasis; Osteolysis; Receptor tyrosine kinase

Indexed keywords

CALCIUM SENSING RECEPTOR; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN;

ANGIOGENESIS; BONE METASTASIS; CALCIUM HOMEOSTASIS; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; EXTRACELLULAR CALCIUM; HORMONE RELEASE; HUMAN; HYPERCALCEMIA; NONHUMAN; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

ANIMALS; HUMANS; HYPERCALCEMIA; MODELS, BIOLOGICAL; NEOPLASMS; PARATHYROID HORMONE-RELATED PROTEIN; RECEPTORS, CALCIUM-SENSING; SIGNAL TRANSDUCTION;

EID: 33646386892     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00350.2005     Document Type: Review

References (120)

1. Aklilu F, Gladu J, Goltzman D, and Rabbani SA. Role of mitogen-activated protein kinases in the induction of parathyroid hormone-related peptide. Cancer Res 60: 1753-1760, 2000.
2. Asakura M, Kitakaze M, Takashima S, Liao Y, Ishikura F, Yoshinaka T, Ohmoto H, Node K, Yoshino K, Ishiguro H, Asanuma H, Sanada S, Matsumura Y, Takeda H, Beppu S, Tada M, Hori M, and Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy. Nat Med 8: 35-40, 2002.
3. Awata H, Huang C, Handlogten ME, and Miller RT. Interaction of the calcium-sensing receptor and filamin, a potential scaffolding protein. J Biol Chem 276: 34871-34879, 2001.
4. 2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 99: 88-96, 1997.
5. 2+ store release. J Biol Chem 273: 21267-21275, 1998.
6. Bikle DD, Ratnam A, Mauro T, Harris J, and Pillai S. Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of the calcium receptor. J Clin Invest 97: 1085-1093, 1996.
7. Bilderback TR, Lee F, Auersperg N, and Rodland KD. Phosphatidylinositol 3-kinase-dependent, MEK-independent proliferation in response to CaR activation. Am J Physiol Cell Physiol 283: C282-C288, 2002.
8. 2+-sensing receptor in the human placenta. Placenta 23: 192-200, 2002.
9. 2+-sensing receptor in cytotrophoblasts from human term placenta. J Endocrinol 156: 425-430, 1998.
10. Brandt DW, Pandol SJ, and Deftos LJ. Calcium-stimulated parathyroid hormone-like protein secretion: potentiation through a protein kinase-C pathway. Endocrinology 128: 2999-3004, 1991.
11. Breitwieser GE, Miedlich SU, and Zhang M. Calcium sensing receptors as integrators of multiple metabolic signals. Cell Calcium 35: 209-216, 2004.
12. 2+-sensing receptor from bovine parathyroid. Nature 366: 575-580, 1993.
13. Brown EM and MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81: 239-297, 2001.
14. Buchs N, Manen D, Bonjour JP, and Rizzoli R. Calcium stimulates parathyroid hormone-related protein production in Leydig tumour cells through a putative cation-sensing mechanism. Eur J Endocrinol 142: 500-505, 2000.
15. Burton DW, Foster M, Johnson KA, Hiramoto M, Deftos LJ, and Terkeltaub R. Chondrocyte calcium-sensing receptor expression is upregulated in early guinea pig knee osteoarthritis and modulates PTHrP, MMP-13, and TIMP-3 expression. Osteoarthritis Cartilage 13: 395-404, 2005.
16. Chakrabarty S, Radjendirane V, Appelman H, and Varani J. Extracellular calcium and calcium sensing receptor function in human colon carcinomas: promotion of E-cadherin expression and suppression of beta-catenin/TCF activation. Cancer Res 63: 67-71, 2003.
17. 2+-sensing receptor in human astrocytes, astrocytomas, and meningiomas. Am J Physiol Cell Physiol 279: C691-C699, 2000.
18. Chattopadhyay N, Mithal A, and Brown EM. The calcium-sensing receptor:a window into the physiology and pathophysiology of mineral ion metabolism. Endocr Rev 17: 289-307, 1996.
19. Chattopadhyay N, Yano S, Tfelt-Hansen J, Rooney P, Kanuparthi D, Bandyopadhyay S, Ren X, Terwilliger E, and Brown EM. Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts. Endocrinology 145: 3451-3462, 2004.
20. Cheng I, Klingensmith ME, Chattopadhyay N, Kifor O, Butters RR, Soybel DI, and Brown EM. Identification and localization of the extracellular calcium-sensing receptor in human breast. J Clin Endocrinol Metab 83: 703-707, 1998.
21. Chirgwin JM, Mohammad KS, and Guise TA. Tumor-bone cellular interactions in skeletal metastases. J Musculoskelet Neuronal Interact 4: 308-318, 2004.
22. Clemens TL, Cormier S, Eichinger A, Endlich K, Fiaschi-Taesch N, Fischer E, Friedman PA, Karaplis AC, Massfelder T, Rossert J, Schluter KD, Silve C, Stewart AF, Takane K, and Helwig JJ. Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol 134: 1113-1136, 2001.
23. 2+-sensing receptor. Proc Natl Acad Sci USA 97: 4814-4819, 2000.
24. Dvorak MM, Siddiqua A, Ward DT, Carter DH, Dallas SL, Nemeth EF, and Riccardi D. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci USA 101: 5140-5145, 2004.
25. Farnebo F, Enberg U, Grimelius L, Backdahl M, Schalling M, Larsson C, and Farnebo LO. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab 82: 3481-3486, 1997.
26. Ferrari SL, Rizzoli R, and Bonjour JP. Effects of epidermal growth factor on parathyroid hormone-related protein production by mammary epithelial cells. J Bone Miner Res 9: 639-644, 1994.
27. Fisher OM, Hart S, Gshwind A, and Ullrich A. EGFR signal transactivation in cancer cells. Biochem Soc Trans 31: 1203-1208, 2003.
28. Garrett JE, Tamir H, Kifor O, Simin RT, Rogers KV, Mithal A, Gagel RF, and Brown EM. Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology 136: 5202-5211, 1995.
29. Gensure RC, Gardella TJ, and Juppner H. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 328: 666-678, 2005.
30. Goodman WG. Calcimimetic agents for the treatment of secondary hyperparathyroidism. Semin Nephrol 24: 460-463, 2004.
31. Grill V, Ho P, Body JJ, Johanson N, Lee SC, Kukreja SC, Moseley JM, and Martin TJ. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 73: 1309-1315, 1991.
32. Guise TA and Mohammad KS. Endothelins in bone cancer metastases. Cancer Treat Res 118: 197-212, 2004.
33. Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, Yoneda T, and Mundy GR. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98: 1544-1549, 1996.
34. Hamid T and Kakar SS. PTTG and cancer. Histol Histopathol 18: 245-251, 2003.
35. Hastings RH, Duong H, Burton DW, and Deftos LJ. Alveolar epithelial cells express and secrete parathyroid hormone-related protein. Am J Respir Cell Mol Biol 11: 701-706, 1994.
36. Heath JK, Southby J, Fukumoto S, O'Keefe LM, Martin TJ, and Gillespie MT. Epidermal growth factor-stimulated parathyroid hormone-related protein expression involves increased gene transcription and mRNA stability. Biochem J 307: 159-167, 1995.
37. Hellman P, Hellman B, Juhlin C, Juppner H, Rastad J, Ridefelt P, and Akerstrom G. Regulation of proliferation in JEG-3 cells by a 500-kDa Ca2+ sensor and parathyroid hormone-related protein. Arch Biochem Biophys 307: 379-385, 1993.
38. Hjalm G, MacLeod RJ, Kifor O, Chattopadhyay N, and Brown EM. Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem 276: 34880-34887, 2001.
39. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG, and Seidman CE. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11: 389-394, 1995.
40. Hobson SA, McNeil SE, Lee F, and Rodland KD. Signal transduction mechanisms linking increased extracellular calcium to proliferation in ovarian surface epithelial cells. Exp Cell Res 258: 1-11, 2000.
41. Horwitz MJ and Stewart AF. Humoral hypercalcemia of malignancy. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, edited by Favus MJ (5th ed.). Philadelphia, PA: Lippincott Williams & Wilkins, 2003, p. 246-250.
42. Hough TA, Bogani D, Cheeseman MT, Favor J, Nesbit MA, Thakker RV, and Lyon MF. Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification. Proc Natl Acad Sci USA 101: 13566-13571, 2004.
43. 2+-sensing receptor: implications for its structure and function. Trends Endocrinol Metab 14: 282-288, 2003.
44. Iguchi H, Tanaka S, Ozawa Y, Kashiwakuma T, Kimura T, Hiraga T, Ozawa H, and Kono A. An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Cancer Res 56: 4040-4043, 1996.
45. Ishikawa H, Heaney AP, Yu R, Horwitz GA, and Melmed S. Human pituitary tumor-transforming gene induces angiogenesis. J Clin Endocrinol Metab 86: 867-874, 2001.
46. Journe F, Dumon JC, Kheddoumi N, Fox J, Laios I, Leclercq G, and Body JJ. Extracellular calcium downregulates estrogen receptor alpha and increases its transcriptional activity through calcium-sensing receptor in breast cancer cells. Bone 35: 479-488, 2004.
47. Kakonen SM and Mundy GR. Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer 97: 834-839, 2003.
48. Kakonen SM, Selander KS, Chirgwin JM, Yin JJ, Burns S, Rankin WA, Grubbs BG, Dallas M, Cui Y, and Guise TA. Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J Biol Chem 277: 24571-24578, 2002.
49. Kallay E, Bajna E, Wrba F, Kriwanek S, Peterlik M, and Cross HS. Dietary calcium and growth modulation of human colon cancer cells: role of the extracellular calcium-sensing receptor. Cancer Detect Prev 24: 127-136, 2000.
50. Kallay E, Bonner E, Wrba F, Thakker RV, Peterlik M, and Cross HS. Molecular and functional characterization of the extracellular calcium-sensing receptor in human colon cancer cells. Oncol Res 13: 551-559, 2003.
51. Kallay E, Kifor O, Chattopadhyay N, Brown EM, Bischof MG, Peterlik M, and Cross HS. Calcium-dependent c-myc proto-oncogene expression and proliferation of Caco-2 cells: a role for a luminal extracellular calcium-sensing receptor. Biochem Biophys Res Commun 232: 80-83, 1997.
52. Keller ET and Brown J. Prostate cancer bone metastases promote both osteolytic and osteoblastic activity. J Cell Biochem 91: 718-729, 2004.
53. Kifor O, MacLeod RJ, Diaz R, Bai M, Yamaguchi T, Yao T, Kifor I, and Brown EM. Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 280: F291-F302, 2001.
54. Kobayashi N, Russell J, Lettieri D, and Sherwood LM. Regulation of protein kinase C by extracellular calcium in bovine parathyroid cells. Proc Natl Acad Sci USA 85: 4857-4860, 1988.
55. Komuves L, Oda Y, Tu CL, Chang WH, Ho-Pao CL, Mauro T, and Bikle DD. Epidermal expression of the full-length extracellular calcium-sensing receptor is required for normal keratinocyte differentiation. J Cell Physiol 192: 45-54, 2002.
56. Kovacs CS. Calcium and bone metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia 10: 105-118, 2005.
57. Kovacs CS, Ho-Pao CL, Hunzelman JL, Lanske B, Fox J, Seidman JG, Seidman CE, and Kronenberg HM. Regulation of murine fetal-placental calcium metabolism by the calcium-sensing receptor. J Clin Invest 101: 2812-2820, 1998.
58. Kremer R, Woodwroth CD, and Goltzman D. Expression and action of parathyroid hormone-related peptide in human cervical epithelial cells. Am J Physiol Cell Physiol 271: C164-C171, 1996.
59. Lala PK and Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2: 149-156, 2001.
60. Lam MH, Briggs LJ, Hu W, Martin TJ, Gillespie MT, and Jans DA. Importin beta recognizes parathyroid hormone-related protein with high affinity and mediates its nuclear import in the absence of importin alpha. J Biol Chem 274: 7391-7398, 1999.
61. Lam MH, House CM, Tiganis T, Mitchelhill KI, Sarcevic B, Cures A, Ramsay R, Kemp BE, Martin TJ, and Gillespie MT. Phosphorylation at the cyclin-dependent kinases site (Thr85) of parathyroid hormone-related protein negatively regulates its nuclear localization. J Biol Chem 274: 18559-18566, 1999.
62. Lin KI, Chattopadhyay N, Bai M, Alvarez R, Dang CV, Baraban JM, Brown EM, and Ratan RR. Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor. Biochem Biophys Res Commun 249: 325-331, 1998.
63. Lindemann RK, Braig M, Hauser CA, Nordheim A, Dittmer J. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells. Biochem J 372: 787-797, 2003.
64. Liu B, Goltzman D, and Rabbani SA. Regulation of parathyroid hormone-related peptide production in vitro by the rat hypercalcemic Leydig cell tumor H-500. Endocrinology 132: 1658-1664, 1993.
65. Luttrell L, Daska Y, and Lefkowitz R. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 11: 177-183, 1999.
66. MacLeod RJ, Chattopadhyay N, and Brown EM. PTHrP stimulated by the calcium-sensing receptor requires MAP kinase activation. Am J Physiol Endocrinol Metab 284: E435-E442, 2003.
67. MacLeod RJ, Yano S, Chattopadhyay N, and Brown EM. Extracellular calcium-sensing receptor transactivates the epidermal growth factor receptor by a triple-membrane-spanning signaling mechanism. Biochem Biophys Res Commun 320: 455-460, 2004.
68. Marti A, Luo Z, Cunningham C, Ohta Y, Hartwig J, Stossel TP, Kyriakis JM, and Avruch J. Actin-binding protein-280 binds the stress-activated protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis factor-activation of SAPK in melanoma cells. J Biol Chem 272: 2620-2628, 1997.
69. McNeil SE, Hobson SA, Nipper V, and Rodland KD. Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium. J Biol Chem 273: 1114-1120, 1998.
70. McNeil L, Hobson S, Nipper V, and Rodland KD. Functional calcium-sensing receptor expression in ovarian surface epithelial cells. Am J Obstet Gynecol 178: 305-313, 1998.
71. Merryman JI, Capen CC, McCauley LK, Werkmeister JR, Suter MM, and Rosol TJ. Regulation of parathyroid hormone-related protein production by a squamous carcinoma cell line in vitro. Lab Invest 69: 347-354, 1993.
72. 2+-sensing receptor is required for L-amino acid sensing. J Biol Chem 279: 51739-51744, 2004.
73. Nebreda AR and Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem Sci 25: 257-260, 2000.
74. Nelson JB. Endothelin inhibition: novel therapy for prostate cancer. J Urol 170: S65-S68, 2003.
75. 2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther 299: 323-331, 2001.
76. Nemeth EF, Steffey ME, Hammerland LG, Hung BC, van Wagenen BC, DelMar EG, and Balandrin MF. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA 95: 4040-4045, 1998.
77. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1: 571-573, 1889.
78. Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, and Shoback D. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 90: 135-141, 2005.
79. Pei L and Melmed S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 11: 433-441, 1997.
80. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297-1303, 1993.
81. 2+-sensing receptor gene mutation. Nat Genet 8: 303-307, 1994.
82. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, and Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884-888, 1999.
83. 2+-sensing receptor: a target for polyamines. Am J Physiol Cell Physiol 273: C1315-C1323, 1997.
84. Rabbani SA, Gladu J, Liu B, and Goltzman D. Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide. Endocrinology 136: 5416-5422, 1995.
85. Riccardi D, Park J, Lee WS, Gamba G, Brown EM, and Hebert SC. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 92: 131-135, 1995.
86. Rizzoli R and Bonjour JP. High extracellular calcium increases the production of parathyroid hormone-like activity by cultured leydig cells associated with humoral hypercalcemia. J Bone Miner Res 4: 839-844, 1989.
87. Rizzoli R, Feyen JHM, Grau G, Wohlwend A, Sappino AP, and Bonjour JP. Regulation of parathyroid hormone-related protein production in a human lung squamous cell carcinoma line. J Endocrinol 143: 333-341, 1994.
88. Rodan SB, Wesolowski G, Ianacone J, Thiede MA, and Rodan GA. Production of parathyroid hormone-like peptide in a human osteosarcoma cell line: stimulation by phorbol esters and epidermal growth factor. J Endocrinol 122: 219-227, 1989.
89. Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, and Blobel CP. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164: 769-779, 2004.
90. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, and Brown EM. Extracellular calcium-sensing receptor (CaR) expression and its potential role in parathyroid hormone-related peptide (PTHrP) secretion in the H-500 rat Leydig cell model of humoral hypercalcemia of malignancy. Biochem Biophys Res Commun 269: 427-432, 2000.
91. 2+-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 281: E1267-E1274, 2001.
92. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Butters RR, and Brown EM. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 141: 4357-4364, 2000.
93. Schafer B, Gschwind A, and Ullrich A. Multiple G-protein receptor signals converge on the epidermal growth factor receptor to promote migration and invasion. Oncogene 23: 991-999, 2004.
94. Schramek H. MAP kinases: from intracellular signals to physiology and disease. News Physiol Sci 17: 62-67, 2002.
95. Sepulveda TVA and Falzon M. Parathyroid hormone-related protein enhances PC-3 prostate cancer cell growth via both autocrine/paracrine and intracrine pathways. Regul Pept 105: 109-120, 2002.
96. Sepulveda TVA, Shen X, and Falzon M. Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells. Endocrinology 143: 596-606, 2002.
97. Silver IA, Murrils RJ, and Etherington DJ. Microlectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 175: 266-276, 1988.
98. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, and Broadus AE. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med 303: 1377-1383, 1980.
99. Strewler GJ and Nissenson RA. Parathyroid hormone-related protein. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (5th ed.). Washington, DC: Am. Soc. Bone and Mineral Research, 2003, p. 125-129.
100. Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Moseley JM, Dieffenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, and Chen EY. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237: 893-896, 1987.
101. Tam CS, Heersche JN, Santora A, and Spiegel AM. Skeletal response in rats following the implantation of hypercalcemia-producing Leydig cell tumors. Metabolism 33: 50-53, 1984.
102. Tfelt-Hansen J, Chattopadhyay N, Yano S, Kanuparthi D, Rooney P, Schwarz P, and Brown EM. Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase but not extracellularly regulated kinase in a model of humoral hypercalcemia of malignancy. Endocrinology 145: 1211-1217, 2004.
103. Tfelt-Hansen J, Ferreira A, Yano S, Kanuparthi D, Romero JR, Brown EM, and Chattopadhyay N. Calcium-sensing receptor activation induces nitric oxide production in H-500 Leydig cancer cells. Am J Physiol Endocrinol Metab 288: E1206-E1213, 2005.
104. Tfelt-Hansen J, MacLeod RJ, Chattopadhyay N, Yano S, Quinn S, Ren X, Terwilliger EF, Schwarz P, and Brown EM. Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells. Am J Physiol Endocrinol Metab 285: E329-E337, 2003.
105. Tfelt-Hansen J, Schwarz P, Terwilliger EF, Brown EM, and Chattopadhyay N. Calcium-sensing receptor induces messenger ribonucleic acid of human securin, pituitary tumor transforming gene, in rat testicular cancer. Endocrinology 144: 5188-5193, 2003.
106. Tfelt-Hansen J, Yano S, John Macleod R, Smajilovic S, Chattopadhyay N, and Brown EM. High calcium activates the EGF receptor potentially through the calcium-sensing receptor in Leydig cancer cells. Growth Factors 23: 117-123, 2005.
107. Thomsen LL and Miles DW. Role of nitric oxide in tumour progression: lessons from human tumours. Cancer Metastasis Rev 17:107-118, 1998.
108. Tomlins SA, Bolllinger N, Creim J, and Rodland KD. Cross-talk between the calcium-sensing receptor and the epidermal growth factor receptor in Rat-1 fibroblasts. Exp Cell Res 308: 439-445, 2005.
109. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, and Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266: 15771-15781, 1991.
110. van Biesen T, Luttrell LM, Hawes BE, and Lefkowitz RJ. Mitogenic signaling via G protein-coupled receptors. Endocr Rev 17: 698-714, 1996..
111. Vanhouten JN. Calcium sensing by the mammary gland. J Mammary Gland Biol Neoplasia 10: 129-139, 2005.
112. Vanhouten J, Dann P, McGeoch G, Brown EM, Krapcho K, Neville M, and Wysolmerski JJ. The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport. J Clin Invest 113: 598-608, 2004.
113. Wada M, Furuya Y, Sakiyama J, Kobayashi N, Miyata S, Ishii H, Nagano N. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor. J Clin Invest 100: 2977-2983, 1997.
114. Ward DT. Calcium receptor-mediated intracellular signalling. Cell Calcium 35: 217-228, 2004.
115. 2+-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J Bone Miner Res 13: 1530-1538, 1998.
116. Yan Y, Shirakabe K, and Werb Z. The metalloprotease Kuzbanian (ADAM 10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol 158: 221-226, 2002.
117. Yano S, Macleod RJ, Chattopadhyay N, Tfelt-Hansen J, Kifor O, Butters RR, and Brown EM. Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation. Bone 35: 664-672, 2004.
118. Yano S, Sugimoto T, Tsukamoto T, Chihara K, Kobayashi A, Kitazawa S, Maeda S, and Kitazawa R. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 58: 1980-1986, 2000.
119. + channel by calcium-sensing receptor involves p38 MAP kinase. J Neurosci Res 75: 491-498, 2004.
120. Yin JJ, Mohammad KS, Kakonen SM, Harris S, Wu-Wong JR, Wessale JL, Padley RJ, Garrett IR, Chirgwin JM, and Guise TA. A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases. Proc Natl Acad Sci USA 100: 10954 -10959, 2003.